Ozempic is a medication that is used to treat type 2 diabetes and has been on the market since 2017. According to the drug patent watch [1], the active ingredient in Ozempic is semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 is a hormone that is produced in the intestines and helps regulate blood sugar levels.

While Ozempic has been shown to be effective in lowering blood sugar levels and promoting weight loss, there are some concerns about its long-term use. According to an article by USA Today [2], some of the potential side effects of Ozempic include nausea, vomiting, and diarrhea. Additionally, there have been reports of pancreatitis and thyroid tumors in animal studies.

Another article by People's Pharmacy [3] also raises concerns about the long-term safety of Ozempic. The article cites a study that found an increased risk of retinopathy, a condition that can lead to vision loss, in patients who took GLP-1 receptor agonists like Ozempic. The article also notes that the long-term effects of Ozempic on the heart and kidneys are not yet known.

In conclusion, while Ozempic has been shown to be effective in treating type 2 diabetes and promoting weight loss, there are some potential side effects and concerns about its long-term safety. Patients who are considering taking Ozempic should discuss the risks and benefits with their healthcare provider.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/OZEMPIC
[2] https://www.usatoday.com/story/news/health/2023/04/02/downside-weight-loss-medication-side-effects-big-pharma/11464954002/
[3] https://www.peoplespharmacy.com/articles/will-ozempic-be-safe-over-the-long-term